Skip to main content
Guidance

COVID-19 vaccine (5 years and over) PGD and VGD

Patient group direction (PGD) and vaccine group direction (VGD) to support the COVID-19 vaccination programme.

Applies to England

Documents

COVID-19 vaccine (5 years and over) patient group direction (PGD)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine (5 years and over) vaccine group direction (VGD)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The aim of the COVID-19 vaccination programme is to prevent serious disease (hospitalisation and/or mortality) arising from COVID-19.

In formulating their advice for COVID-19 vaccination in autumn 2026 and spring 2027, the Joint Committee on Vaccination and Immunisation (JCVI) considered the latest COVID-19 epidemiology, vaccine coverage and safety data.

The PGD and VGD are final versions with NHS England authorisation for use by their commissioned providers delivering the national COVID-19 vaccination programme. Practitioners should follow local policy and procedures to access authorised PGD or VGD documents.

The PGD and VGD documents support the administration of COVID-19 vaccines, to individuals from 5 years of age, in accordance with the national COVID-19 vaccination programme and recommendations given in the COVID-19 chapter of Immunisation Against Infectious Disease: The Green Book.

COVID-19 vaccine (5 years and over) patient group direction (PGD) version 5.0 is valid from 1 October 2026 to 1 April 2027.

COVID-19 vaccine (5 years and over) vaccine group direction (VGD) version 2.0 is valid from 1 October 2026 to 1 April 2027.

The PGD/VGD documents should be used with reference to current national guidance, the Green Book, and summary of product characteristics (SPC) for the vaccine.

Updates to this page

Published 16 September 2026

Sign up for emails or print this page